Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
7 studies found for:    Alkermes | Canada
Show Display Options
Rank Status Study
1 Completed A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study
Condition: Major Depressive Disorder
Interventions: Drug: ALKS 5461;   Drug: Placebo
2 Completed A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study
Condition: Major Depressive Disorder
Interventions: Drug: High Dose ALKS 5461;   Drug: Low Dose ALKS 5461;   Drug: Placebo
3 Active, not recruiting A Long-Term Safety Study of ALKS 5461
Condition: Major Depressive Disorder
Intervention: Drug: ALKS 5461
4 Completed Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
Conditions: Diabetes Mellitus;   Asthma;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: injected insulin
5 Completed Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Injectable Insulin;   Drug: Insulin Glargine
6 Completed Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Insulin Glargine
7 Completed A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Intervention: Drug: ALKS 5461

Study has passed its completion date and status has not been verified in more than two years.